Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
Trial ID or NCT#
Status
Purpose
The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.
Official Title
Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
Eligibility Criteria
- - Overweight/obese (BMI 25-40 kg/m2) - Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
- - On glucose-lowering medications (e.g., metformin) - On weight-loss medications
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Associate Professor
650-723-8284
View on ClinicalTrials.gov